Supernus completes Indivior merger, forming diversified CNS biopharma leader
Supernus Pharmaceuticals (Nasdaq: SUPN) has completed its merger with Indivior Pharmaceuticals, per a Globe Newswire release. The combination officially launches the new Supernus as a diversified CNS biopharmaceutical leader, expanding its central nervous system portfolio.
Source:
globenewswire.com: https://www.globenewswire.com/news-release/2026/11/02/3393272/19871/en/supernus-and-indivior-complete-merger-creating-a-diversified-cns-biopharmaceutical-leader.html
Not financial advice. For informational and educational purposes only.
Video explainer: Marvell just agreed to buy Lumentum for $115 billion in stock. One of the biggest tech deals ever and it's really a bet on lasers 🔦
Marvell just agreed to buy Lumentum for $115 billion in stock. One of the biggest tech deals ever and it's really a bet on lasers 🔦 Lumentum holders get 4.5 Marvell…
Anthropic files amended IPO prospectus showing Q3 revenue up 12x to ~$17B
Anthropic filed an amended S-1 disclosing Q3 revenue of nearly $17 billion, up 12x year-over-year,…
Mark Zuckerberg
Mark Zuckerberg has run Meta (formerly Facebook) for 22 years, the only CEO it has ever had. The latest reinvention: personal superintelligence, his framing for Meta's AI push. He co-founded Facebook in February 2004 from a Harvard dorm room with several classmates, dropping out as a sophomore. He opened the platform beyond college in 2006, took the company public in…
1929 Crash & Depression — 25 Years to a New High, Then Six Months
The Dow's 51,770.31 close is roughly 136 times its 1929 peak, and the post explains why banking safeguards matter more than recovery speed.
The Dow Jones Industrial Average posted a closing peak of 381.17 on September 3, 1929. It closed Friday at 51,770.31, roughly 136 times that level. Ninety-seven years separate an era of thinly backstopped speculation from one with layered safeguards, but the history of crash recoveries is messier than a clean story of progress.